期刊
ACTA NEUROPATHOLOGICA
卷 123, 期 6, 页码 841-852出版社
SPRINGER
DOI: 10.1007/s00401-011-0938-4
关键词
Glioblastoma; Glioblastoma with oligodendroglioma-like component; MGMT; IDH1; EGFR; Pathology; Temozolomide; Randomized trial; Pseudopalisading necrosis; Prognostic factors
资金
- Swiss National Science Foundation [3100A0_122557/1]
- Amadeo and Nelia Barletta Foundation
- Jacqueline Seroussi Foundation
- EORTC [TRF/04/01, TRF/02/03]
- National Cancer Institute (Bethesda, Maryland, USA) [5U10 CA11488-30, 2U10 CA011488-41]
- EORTC Charitable Trust
Glioblastoma (GBM) is a morphologically heterogeneous tumor type with a median survival of only 15 months in clinical trial populations. However, survival varies greatly among patients. As part of a central pathology review, we addressed the question if patients with GBM displaying distinct morphologic features respond differently to combined chemo-radiotherapy with temozolomide. Morphologic features were systematically recorded for 360 cases with particular focus on the presence of an oligodendroglioma-like component and respective correlations with outcome and relevant molecular markers. GBM with an oligodendroglioma-like component (GBM-O) represented 15% of all confirmed GBM (52/339) and was not associated with a more favorable outcome. GBM-O encompassed a pathogenetically heterogeneous group, significantly enriched for IDH1 mutations (19 vs. 3%, p = 0.003) and EGFR amplifications (71 vs. 48%, p = 0.04) compared with other GBM, while co-deletion of 1p/19q was found in only one case and the MGMT methylation frequency was alike (47 vs. 46%). Expression profiles classified most of the GBM-O into two subtypes, 36% (5/14 evaluable) as proneural and 43% as classical GBM. The detection of pseudo-palisading necrosis (PPN) was associated with benefit from chemotherapy (p = 0.0002), while no such effect was present in the absence of PPN (p = 0.86). In the adjusted interaction model including clinical prognostic factors and MGMT status, PPN was borderline nonsignificant (p = 0.063). Taken together, recognition of an oligodendroglioma-like component in an otherwise classic GBM identifies a pathogenetically mixed group without prognostic significance. However, the presence of PPN may indicate biological features of clinical relevance for further improvement of therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据